Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FREEDOM COVID Anticoagulation Strategy Randomized Trial

NCT04512079 is registered in ClinicalTrials.gov with Valentin Fuster as lead sponsor.

NCT NCT04512079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04512079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FREEDOM COVID Anticoagulation Strategy Randomized Trial
Lead sponsor
Valentin Fuster
Phase
Phase 4
Overall status
Completed
Start date
September 8, 2020
Completion date
December 30, 2022
Enrollment
3,460 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sars-cov-2